Translational Psychiatry · 2022 · 22 citations · 58 references
MedicinePediatricsPsychiatryAutism Spectrum DisordersChild PsychiatryNeuropsychiatryAttention-deficit/hyperactivity DisorderNeurodevelopmental DisordersNeurodevelopmental EpidemiologyPediatric NeuropsychiatryAttention Deficit Hyperactivity Disorder ComorbidityAttention-deficit/hyperactivity Disorder EpidemiologyChildhood AdhdComorbid Attention Deficit Hyperactivity DisorderNeurodevelopmental Outcomes After Prenatal ExposureNeurodevelopmental Sequelae Of Amino Acid DisordersPrevalence Of Mental DisordersTryptophan Metabolism
Alterations in tryptophan and serotonin have been implicated in various mental disorders; but studies are limited on child neurodevelopmental disabilities such as autism spectrum disorder (ASD) and attention-deficit hyperactivity disorder (ADHD). This prospective cohort study examined the associations between levels of tryptophan and select metabolites (5-methoxytryptophol (5-MTX), 5-hydroxytryptophan (5-HTP), serotonin, N-acetyltrytophan) in cord plasma (collected at birth) and physician-diagnosed ASD, ADHD and other developmental disabilities (DD) in childhood. The study sample (n = 996) derived from the Boston Birth Cohort, which included 326 neurotypical children, 87 ASD, 269 ADHD, and 314 other DD children (mutually exclusive). These participants were enrolled at birth and followed-up prospectively (from October 1, 1998 to June 30, 2018) at the Boston Medical Center. Higher levels of cord 5-MTX was associated with a lower risk of ASD (aOR: 0.56, 95% CI: 0.41, 0.77) and ADHD (aOR: 0.79, 95% CI: 0.65, 0.96) per Z-score increase, after adjusting for potential confounders. Similarly, children with cord 5-MTX ≥ 25th percentile (vs. <25th percentile) had a reduction in ASD (aOR: 0.27, 95% CI: 0.14, 0.49) and ADHD risks (aOR: 0.45, 95% CI: 0.29, 0.70). In contrast, higher levels of cord tryptophan, 5-HTP and N-acetyltryptophan were associated with higher risk of ADHD, with aOR: 1.25, 95% CI: 1.03, 1.51; aOR: 1.32, 95% CI: 1.08, 1.61; and aOR: 1.27, 95% CI: 1.05, 1.53, respectively, but not with ASD and other DD. Cord serotonin was not associated with ASD, ADHD, and other DD. Most findings remained statistically significant in the sensitivity and subgroup analyses.
58
The health status of adults on the autism spectrum
Lisa Croen, Ousseny Zerbo, Yinge Qian et al. · Autism · 2015 · 1.1K citations
Education, Pediatrics, Psychiatry +10
Maternal Cigarette Smoking, Metabolic Gene Polymorphism, and Infant Birth Weight
Xiaobin Wang · JAMA · 2002 · 619 citations
A transient placental source of serotonin for the fetal forebrain
Alexandre Bonnin, Nick Goeden, Kevin Chen et al. · Nature · 2011 · 598 citations · Full text
Abnormal melatonin synthesis in autism spectrum disorders
Jonas Melke, Hany Goubran Botros, Pauline Chaste et al. · Molecular Psychiatry · 2007 · 524 citations · Full text
Nursing, Neurobiology, Neuroscience +12